Welcome to the Bioasis Technologies Hub On AGORACOM

Free
Message: Bioasis Announces Positive Results from NHP study w/ xB³-001

Bear I should add to the last point, that Bioasis is now seeking approval for a clinical trial.

Is that correct?

" xB3-001 attached to Trastuzumab helps it (TZM) to cross the BBB to attack HER2- expressing breast cancer that has spread to the brain. "

 

Koo

Share
New Message
Please login to post a reply